About Anushka Dutta
With a master's degree in economics, she aims to help investors identify untapped investment opportunities by looking at the fundamental factors.
Recent Articles By Anushka Dutta
3 Pricey Tech Stocks to Avoid in July
The tech sector has been facing significant challenges due to rising interest rates. Many tech companies are freezing hiring and laying off employees to prepare for a potential recession. With declining investors’ confidence in the sector, pricey tech stocks Aurora Innovation (AUR), Meta Materials (MMAT), and Ondas Holdings (ONDS) might be best avoided in July. Keep reading...
Investors Love Bayer, but the Courts Don’t – Buy, Sell, Hold?
Life sciences company Bayer (BAYRY) is currently facing a legal challenge concerning its Roundup. However, farmers have supported the company. On the other hand, despite the market volatility, the stock has been gaining in price. So, is the stock a Buy, Sell, or Hold now? Read on to find out…
2 Low-Beta Mega Stocks That Could Outperform the Market
The stock market has witnessed a free fall since the beginning of the year due to the Fed’s interest rate hikes and the recession fears. Moreover, interest rates are expected to rise further this year. Given the heightened volatility in the market, we think low beta mega stocks Johnson & Johnson (JNJ) and Coca-Cola (KO) might be solid buys. Read on…
4 Pharmaceutical Stocks with Tremendous Growth Potential
The global pharmaceutical industry has witnessed robust growth over the past few years. The rapidly aging population and continued breakthroughs in drug development are expected to keep driving the industry’s growth. Thus, we think pharmaceutical stocks Assertio Holdings (ASRT), Bayer (BAYRY), Eagle Pharmaceuticals (EGRX), and Merck (MRK), which possess solid growth attributes, could be solid investments now. Read on...
Groupon Still Not “Buy” After New Turnaround Plan
Marketplace operator Groupon (GRPN) is currently focusing on its new turnaround plan. However, the stock has plunged more than 40% this year, and I think it is not the right time to invest in it. Read more to find out why…
Top Analyst Recommends These 2 Buy-Rated Freight Stocks
The coronavirus pandemic has led to a rise in freight costs, which are expected to remain elevated due to the war and the supply chain issues. Amid this, analyst Jason Seidl has recommended freight stocks Hub Group (HUBG) and XPO Logistics (XPO), which are rated Buy in our proprietary rating system. Read on…
3 Safe Consumer Staples Stocks to Buy in a Down Market
The stock market has been witnessing wild swings lately, with the Fed’s rate hikes to tame inflation and the recessionary concerns. However, the non-cyclical nature of consumer staples could help Embotelladora Andina (AKO.B), JBS S.A. (JBSAY), and Mannatech (MTEX) to generate stable returns. Thus, we think these stocks could be ideal additions to your portfolio amid the market downturn. Keep reading…
3 Safe Consumer Staples Stocks To Buy In A Down Market
The stock market has been witnessing wild swings lately, with the Fed’s rate hikes to tame inflation and the recessionary concerns. However, the non-cyclical nature of consumer staples could help consumer staples stocks Embotelladora Andina (AKO-B), JBS S.A. (JBSAY), and Mannatech (MTEX) to generate stable returns. Thus, we think these stocks could be ideal additions to your portfolio amid the market downturn. Keep reading…
Is It Time To Buy Alibaba?
Chinese tech giant Alibaba (BABA) has demonstrated significant revenue growth in its last reported quarter. However, its top-line growth did not translate to bottom-line improvement. With the stock down 48% over the past year, will it be wise to invest in it now? Read on to find out...